Generex Biotechnology Corp. (fka GNBTQ)

[RoswellChamp]

I'm not sure I know the answer, maybe someone else could weigh in. I do know they want to get the stock above that "magic" $5.00 level to make it more attractive to institutional investors and to help qualify for a listing on an exchange.

The problem with the listing aspect is there are additional requirements for a listing such as earnings, profitability, history, net worth, etc. Not all may be required by all exchanges and the requirements differ (you could research that) but it is not strictly stock price.

As to raising money, I guess a $8.00 or $9.00 stock looks better to a potential partner, but that alone is not going to do it. Any such investor would certainly know the history of GNBT and it got up to that price, and it has no effect whatsoever on the underlying fundamentals for the company.

So, in a nutshell, like I said, I'm not sure what good the R/S will do.

What will help the stock price go up and stay up is some actual news about one of their products or technologies or patents or something. That is always what they have needed and been unable to produce.